204 related articles for article (PubMed ID: 12578823)
21. p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation.
Radfar A; Unnikrishnan I; Lee HW; DePinho RA; Rosenberg N
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13194-9. PubMed ID: 9789064
[TBL] [Abstract][Full Text] [Related]
22. ARF tumor suppressor induces mitochondria-dependent apoptosis by modulation of mitochondrial Bcl-2 family proteins.
Nakazawa Y; Kamijo T; Koike K; Noda T
J Biol Chem; 2003 Jul; 278(30):27888-95. PubMed ID: 12740365
[TBL] [Abstract][Full Text] [Related]
23. p19ARF determines the balance between normal cell proliferation rate and apoptosis during mammary gland development.
Yi Y; Shepard A; Kittrell F; Mulac-Jericevic B; Medina D; Said TK
Mol Biol Cell; 2004 May; 15(5):2302-11. PubMed ID: 15105443
[TBL] [Abstract][Full Text] [Related]
24. p53-independent functions of the p19(ARF) tumor suppressor.
Weber JD; Jeffers JR; Rehg JE; Randle DH; Lozano G; Roussel MF; Sherr CJ; Zambetti GP
Genes Dev; 2000 Sep; 14(18):2358-65. PubMed ID: 10995391
[TBL] [Abstract][Full Text] [Related]
25. Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways.
Weber HO; Samuel T; Rauch P; Funk JO
Oncogene; 2002 May; 21(20):3207-12. PubMed ID: 12082636
[TBL] [Abstract][Full Text] [Related]
26. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
27. Different requirements for the cytostatic and apoptotic effects of type I interferons. Induction of apoptosis requires ARF but not p53 in osteosarcoma cell lines.
Sandoval R; Xue J; Pilkinton M; Salvi D; Kiyokawa H; Colamonici OR
J Biol Chem; 2004 Jul; 279(31):32275-80. PubMed ID: 15169789
[TBL] [Abstract][Full Text] [Related]
28. Bach1-mediated suppression of p53 is inhibited by p19(ARF) independently of MDM2.
Nishizawa H; Ota K; Dohi Y; Ikura T; Igarashi K
Cancer Sci; 2012 May; 103(5):897-903. PubMed ID: 22348305
[TBL] [Abstract][Full Text] [Related]
29. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
Haviernik P; Schmidt M; Hu X; Wolff L
Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
[TBL] [Abstract][Full Text] [Related]
30. Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis.
Moore L; Venkatachalam S; Vogel H; Watt JC; Wu CL; Steinman H; Jones SN; Donehower LA
Oncogene; 2003 Oct; 22(49):7831-7. PubMed ID: 14586409
[TBL] [Abstract][Full Text] [Related]
31. The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development.
McKeller RN; Fowler JL; Cunningham JJ; Warner N; Smeyne RJ; Zindy F; Skapek SX
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3848-53. PubMed ID: 11891301
[TBL] [Abstract][Full Text] [Related]
32. p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice.
Shank-Calvo JA; Draheim K; Bhasin M; Kelliher MA
Oncogene; 2006 May; 25(21):3023-31. PubMed ID: 16407836
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.
Lin AW; Lowe SW
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5025-30. PubMed ID: 11309506
[TBL] [Abstract][Full Text] [Related]
34. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
Hemmati PG; Gillissen B; von Haefen C; Wendt J; Stärck L; Güner D; Dörken B; Daniel PT
Oncogene; 2002 May; 21(20):3149-61. PubMed ID: 12082630
[TBL] [Abstract][Full Text] [Related]
35. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
36. p19(Arf) is required for the cellular response to chronic DNA damage.
Bieging-Rolett KT; Johnson TM; Brady CA; Beaudry VG; Pathak N; Han S; Attardi LD
Oncogene; 2016 Aug; 35(33):4414-21. PubMed ID: 26725325
[TBL] [Abstract][Full Text] [Related]
37. Small mitochondrial Arf (smArf) protein corrects p53-independent developmental defects of
van Oosterwijk JG; Li C; Yang X; Opferman JT; Sherr CJ
Proc Natl Acad Sci U S A; 2017 Jul; 114(28):7420-7425. PubMed ID: 28652370
[TBL] [Abstract][Full Text] [Related]
38. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
39. miR-34a is essential for p19(Arf)-driven cell cycle arrest.
Iqbal N; Mei J; Liu J; Skapek SX
Cell Cycle; 2014; 13(5):792-800. PubMed ID: 24401748
[TBL] [Abstract][Full Text] [Related]
40. The ARF tumor suppressor: keeping Myc on a leash.
Gregory MA; Qi Y; Hann SR
Cell Cycle; 2005 Feb; 4(2):249-52. PubMed ID: 15655352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]